TG Therapeutics Inc (TGTX)

28.77 +0.77 (+2.75%) USD  |  NASDAQ  |  Jan 08, 16:00
28.96 +0.19 (+0.66%) After-Hours: 20:00
More

TG Therapeutics SG&A Expense (Quarterly): 41.97M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for TGTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Zoetis Inc 565.00M
Rhythm Pharmaceuticals Inc 35.38M
Warby Parker Inc 111.48M
NovaBay Pharmaceuticals Inc 2.65M
Palatin Technologies Inc 2.021M